Similar articles

• Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.

  Shi W, Arnold GS, Bartlett JS. Shi W, et al. Hum Gene Ther. 2001 Sep 20;12(14):1697-711. doi: 10.1089/104303401750476212. Hum Gene Ther. 2001. PMID: 11560765
• Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.

  Flannery JG, Visel M. Flannery JG, et al. Methods Mol Biol. 2013;935:351-69. doi: 10.1007/978-1-62703-080-9_25. Methods Mol Biol. 2013. PMID: 23150381
• Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system.

  Klein RL, Mandel RJ, Muzyczka N. Klein RL, et al. Adv Virus Res. 2000;55:507-28. doi: 10.1016/s0065-3527(00)55015-5. Adv Virus Res. 2000. PMID: 11050954 No abstract available.
• Adenovirus and adeno-associated virus mediated gene transfer.

  Kremer EJ, Perricaudet M. Kremer EJ, et al. Br Med Bull. 1995 Jan;51(1):31-44. doi: 10.1093/oxfordjournals.bmb.a072951. Br Med Bull. 1995. PMID: 7767647 Review.
• Gene therapy for pulmonary diseases.

  Kolb M, Martin G, Medina M, Ask K, Gauldie J. Kolb M, et al. Chest. 2006 Sep;130(3):879-84. doi: 10.1378/chest.130.3.879. Chest. 2006. PMID: 16963689 Review.